Connect with us

Digital Health

AI tool outperforms prior methods in colorectal cancer analysis

Researchers from the University of Jyväskylä in collaboration with the Institute of Biomedicine University of Turku and Nova Central Finland have developed…

Published

on

This article was originally published by BioEngineering

Researchers from the University of Jyväskylä in collaboration with the Institute of Biomedicine University of Turku and Nova Central Finland have developed an artificial intelligence tool for automatic colorectal cancer tissue analysis. The refined neural network outperformed all previous solutions in the task. The neural network offers a faster, more precise method for classifying colorectal cancer tissue images from microscope slides. This could significantly reduce the workload of histopathologists, leading to quicker insights, prognoses, and diagnoses.

Each dot represents an image piece from a cancer microscope slide.

Credit: Fabi Prezja

Researchers from the University of Jyväskylä in collaboration with the Institute of Biomedicine University of Turku and Nova Central Finland have developed an artificial intelligence tool for automatic colorectal cancer tissue analysis. The refined neural network outperformed all previous solutions in the task. The neural network offers a faster, more precise method for classifying colorectal cancer tissue images from microscope slides. This could significantly reduce the workload of histopathologists, leading to quicker insights, prognoses, and diagnoses.

Public Accessibility for Future Advancements

In a significant nod to open science and cooperative growth, the researchers are making the trained neural network tool available to the public. This gesture is intended to spur further advancements by inviting scientists, researchers, and developers globally to refine its capabilities and investigate new applications. 

“By granting universal access, the aim is to fast-track breakthroughs in colorectal cancer research”, adds Fabi Prezja, who was responsible for the design of the method.

Stringent Clinical Validation is Imperative

While the results are promising, it’s crucial to adopt AI in clinical settings judiciously. The calibre and diversity of medical data are central to the success of AI-driven methods. As these AI solutions inch closer to routine clinical implementation, it’s imperative they undergo stringent clinical validation to ensure their outcomes consistently align with clinical standards.

 


artificial intelligence

Digital Health

Keep it Short

By KIM BELLARD OK, I admit it: I’m on Facebook. I still use Twitter – whoops, I mean X. I have an Instagram account but don’t think I’ve ever posted….

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading
Digital Health

Seattle startup Olamedi building platform to automate health clinic communications

A new Seattle startup led by co-founders with experience in health tech is aiming to automate communication processes for healthcare clinics with its software…

Continue Reading

Trending